Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines-Reference-Cited by-同舟云学术

Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines

Published:2015-12 Issue: Volume:1 Page:90-100
ISSN:2405-8521
Container-title:Papillomavirus Research
language:en
Short-container-title:Papillomavirus Research

Author:

Hartwig Susanne,Baldauf Jean-Jacques,Dominiak-Felden Géraldine,Simondon François,Alemany Laia,de Sanjosé Silvia,Castellsagué Xavier

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference31 articles.

1. IARC: Monographs on the Evaluation on Carcinogenic Risks to Humans. Volume 100: A Review of Human Carcinogens. Part B: Biological Agents, Lyon: International Agency for Research on Cancer, 2012

2. European Centers for Disease Prevention and Control: Introduction of HPV Vaccines in EU Countries—An Update. Stockholm: European Centers for Disease Prevention and Control, 2012.

3. Fall in human papillomavirus prevalence following a national vaccination program;Tabrizi;J. Infect. Dis.,2012

4. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review;Mariani;Adv Ther,2015

5. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study;Brotherton;Lancet,2011

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil;PLOS ONE;2024-06-11

2. Knowledge and beliefs of Greek parents towards HPV infection and vaccination – are they willing to vaccinate their sons?;International Journal of Adolescent Medicine and Health;2024-02-02

3. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial;The Lancet Infectious Diseases;2023-11

4. External validation of a radiomic signature to predict p16 (HPV) status from standard CT images of anal cancer patients;Scientific Reports;2023-05-03

5. Economic Burden of Cervical Cancer in Bulgaria;International Journal of Environmental Research and Public Health;2023-02-03